marcus evans europe conferences

Clinical Trials Optimisation & Patient Centricity

Reduce Costs, Speed up Processes, Leverage your Data, Embrace New Models of Studies, Create Robust Protocols and Designs, Improve your Partnerships, Learn the Last Technology Updates & Let Patients Become True Partners

30 September-2 October 2019
Barcelona, Spain

Why You Should Attend

Clinical Trials Optimisation & Patient Centricity

This new marcus evans conference will dive into one of the most complex and expensive stages of the development of a novel drug, the development, management, design and organisation of clinical trials. In a time when clinical trials can cost millions, therapies are becoming more and more specific and studies are expanding internationally, there is an increasing need to create robust protocols, meticulous designs and successful partnerships. This new event will not only focus on budget and resource forecasting and controlling, risk management, site activation and CROs partnerships but will also review new trends on the rise such us blockchain, RWE, biomarkers and digital innovative solutions. Our focus will also be towards patients, who have become a pivotal element for clinical trials‘ performance and success.

We aim to bring together the voice of different experts in operations, planning, innovation and coordination of clinical trials, leverage the opinion of all stakeholders and be the catalyst of highly relevant conversations that bring solutions and enhance the performance of an essential gear of the drug development machine.

Key Topics

  • Biogen presenting blockchain strategies for Pharma
  • Bayer assessing resource and budget forecasting models
  • Hospital Vall D´Hebron presenting how to reach the public during the first stages
  • Janssen & Sanofi showcasing the digital advances in clinical trials
  • Roche discussing the best clinical trials design approaches
  • Previous Attendees Include

    Abbott Bioresearch Centre
    Bayer Healthcare
    Biogen Idec
    Boehringer Ingelheim
    Bristol-Myers Squibb
    Daiichi Sankyo Group
    Eli Lilly and Company
    Janssen Pharmaceutical
    Johnson & Johnson
    Merck & Co
    Mitsubishi Tanabe Pharmaceuticals
    Novartis Pharma AG
    Roche Biologics
    Shire Pharmaceutical

    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.

    Event Partners

    Practical Insights From

    José Manuel Ordoñez
    CCO Therapeutic Area Leader Onco-Haematology

    Michael Makanga
    Executive Director
    European & Developing Countries Clinical Trials Partnership (EDCTP)

    Magali Taiel
    VP Clinical Development
    Gensight Biologics

    Ángela Quintana
    Oncology Clinical Trials Coordinator
    Hospital VallD’Hebron

    Adama Ibrahim
    Global Clinical Operations BlockChain Advisor

    Aji Barot
    VP Pharma (EMEA)

    Susanne Mersmann
    Senior Resource Manager

    Click Here For Full Agenda

    Voice of Our Customers
    • “Great. Enjoyed networking” Eisai
    • “Great gathering of professionals in the alliance management” UCB
    • “Overall very good” Merck
    • “Very well organized” Sanofi
    Latest Conference News & Resources

    Join the Discussion

    Follow on LinkedIn

    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Anastasia Zardili

    9 Dimostheni Severi Street
    Nicosia 1080